GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults
GSK plc (NYSE:GSK) released topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety of Arexvy (Respiratory Syncytial Virus Vaccine) when co-administered with Shingrix (Zoster Vaccine).
GSK Shingles Vaccine in Malaysia: Here’s What You Need to Know
GSK has launched it's Shingles vaccine in Malaysia and here's all you need to know about it. From what it is, to the side effects, for whom and where to get it.
GSK's RSV, Shingles vaccines show on-par immune response in joint trial
(Reuters) -British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot together generated the same immune response in a late-stage trial as separate adminstration of the vaccines.
GSK shingles vaccine now available in Malaysia
GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced the launch of its Herpes Zoster vaccine, Shingrix (MAL24056002ARZ), also known as Recombinant Zoster Vaccine, Adjuvanted (RZV) in Malaysia for the prevention of shingles (herpes zoster,
GSK Sees Positive Results in Trial of Combination RSV, Shingles Vaccine
GSK recorded positive topline data in a late stage trial of its respiratory syncytial virus vaccine combined with a shingles vaccine in treating adults 50 years and older. The British pharma giant said Wednesday a Phase 3 study evaluating RSV vaccine Arexvy co-administered with Shingrix met the primary endpoint,
GSK's RSV vaccine meets main goal when co-administered with shingles shot
British drugmaker GSK said on Wednesday its respiratory syncytial virus (RSV) vaccine, when given together with its shingles shot, met the main goal of a late-stage trial in adults over 50 years of age.
GSK Reports Positive Data From Co-administration Of RSV And Shingles Vaccines
GSK plc (GSK, GSK.L) announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the
Money Talks News on MSN4h
This Vaccine Is Now Tied to a 17% Lower Dementia Risk
Getting the Shingrix vaccine after the age of 50 can reduce your chances of developing the painful skin condition known as ...
6 Essential Vaccines To Combat Lung-Related Illnesses In India
Respiratory diseases are on a continuous rise in India that escalates when there is a change in weather. Health experts ...
American States Ranked by the Highest and Lowest Vaccination Rates
Rhode Island has the highest vaccination rate across the country, while Mississippi was found to have the lowest, a new study ...
More Australians will be able to get a free vaccine for shingles
More Australians will be able to get a free vaccine for the painful condition shingles. Aussies ages 18 to 64 who are classed ...
health.economictimes.indiatimes1d
Voluntary vaccination among adults can significantly reduce lung infections incidence
It is important for vulnerable people and the elderly to stay up to date on vaccinations such as influenza (to protect ...
clinicaladvisor.com16d
Shingles Vaccine May Lower Dementia Risk, Increases Diagnosis-Free Time
Researchers conducted an observational study to compare the risk for dementia associated with both the live and recombinant shingles vaccines.
Armed robbery in Revesby3d
More Australians to Get Funded Shingles Vaccine
Melbourne, Australia The Government has expanded access to GSK's shingles vaccine, Shingrix, to cover individuals aged 18 ...
Medindia6h
Adult Vaccination: A Shield Against Lung Diseases in India
However, the current rate of adult vaccination in India is minuscule due to which millions of individuals remain vulnerable ...
GEN14d
Increasing Vaccine Efficacy with Novel Adjuvants
Derived from the Latin adjuvare (to help or aid), adjuvants enhance antigen-specific vaccine immunogenicity. Added only when ...